Get started
Author

Katharina F. Bergerhoff

Observed names: Bergerhoff, Katharina, K. Bergerhoff, KF Bergerhoff, Katharina Bergerhoff
ORCID: 0000-0001-5105-6221
Observed ORCID: 0000-0001-5105-6221
OpenAlex ID: A5048840550
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 · Tyler R. Simpson, Fubin Li, et al. · The Journal of Experimental Medicine · 1,471
Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells
2020 · Anna Śledzińska, Maria Vila de Mucha, et al. · Immunity · 227
PDF
ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment
2019 · Magnus T. Dillon, Katharina F. Bergerhoff, et al. · Clinical Cancer Research · 201
Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy
2015 · Anna Śledzińska, Laurie Menger, et al. · Molecular Oncology · 93
PDF
TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors
2016 · Laurie Menger, Anna Sledzinska, et al. · Cancer Research · 79
TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cells
2015 · Laurie Menger, Agnes Gouble, et al. · Blood · 58
Cellular Selectivity and Biological Impact of Cytotoxic Rhodium(III) and Iridium(III) Complexes Containing Methyl‐Substituted Phenanthroline Ligands
2011 · Yvonne Geldmacher, Igor Kitanovic, et al. · ChemMedChem · 40
The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent Mechanism
2020 · Martin McLaughlin, Malin Pedersen, et al. · Molecular Therapy — Oncolytics · 37
PDF
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer
2020 · Eva Crespo-Rodriguez, Katharina Bergerhoff, et al. · Journal for ImmunoTherapy of Cancer · 34
PDF
PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma
2019 · Henry G. Smith, David Mansfield, et al. · Clinical Cancer Research · 27
ENTPD3-specific CAR regulatory T cells for local immune control in T1D
2024 · Tom Pieper, Tobias Riet, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 7
Isolation and Analysis of Tumor-Infiltrating Treg
2022 · Katharina Bergerhoff, Malin Pedersen · Methods in molecular biology · 6
Case Study: Holotomography reveals insights into chemotherapy response of heterogeneous breast cancer patient derived tumoroids Patient derived tumoroid drug screening by combining Okomera's microfluidic platform and Tomocube holotomography
2025 · Mercier, Lucile, Lee, Jaehyeok, et al. · HAL (Le Centre pour la Communication Scientifique Directe)
338P End-to-end automated organoid screening platform: Application in breast cancer drug screening
2025 · L. Mercier, A. DECHELETTE, et al. · Annals of Oncology
Data from TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors
2023 · Laurie Menger, Anna Sledzinska, et al.
Supplemental Figures from TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors
2023 · Laurie Menger, Anna Sledzinska, et al.
PDF
Supplemental Figure Legends from TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors
2023 · Laurie Menger, Anna Sledzinska, et al.
Supplemental Figure Legends from TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors
2023 · Laurie Menger, Anna Sledzinska, et al.
Supplemental Figures from TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors
2023 · Laurie Menger, Anna Sledzinska, et al.
Supplementary Data from ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment
2023 · Magnus T. Dillon, Katharina F. Bergerhoff, et al.
Supplementary Data from PD-1 Blockade Following Isolated Limb Perfusion with Vaccinia Virus Prevents Local and Distant Relapse of Soft-tissue Sarcoma
2023 · Henry G. Smith, David Mansfield, et al.
Supplemental Figures from TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors
2023 · Laurie Menger, Anna Sledzinska, et al.
Supplemental Figure Legends from TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors
2023 · Laurie Menger, Anna Sledzinska, et al.
Supplemental Figures from TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors
2023 · Laurie Menger, Anna Sledzinska, et al.
Supplemental Figure Legends from TALEN-Mediated Inactivation of PD-1 in Tumor-Reactive Lymphocytes Promotes Intratumoral T-cell Persistence and Rejection of Established Tumors
2023 · Laurie Menger, Anna Sledzinska, et al.
Works count: 36
Citation count: 2,279
H-index: 10
I10-index: 10
Year
Topic
Type